Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 12, Issue 2, 2000, Pages 233-239

  Kaufer, Daniel I ^a,c   Cummings, Jeffrey L ^a,b   Ketchel, Patrick ^a,b   Smith, Vanessa ^a,b   MacMillan, Audrey ^a,b   Shelley, Timothy ^a,b   Lopez, Oscar L ^a,b   DeKosky, Steven T ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RELIABILITY; VALIDATION PROCESS;

EID: 0034028609     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.12.2.233     Document Type: Article

References (25)

1. Cummings JL, Victoroff JL: Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1990; 3:140-158
2. Reisberg B, Franssen E, Scalan SG, et al: BEHAVE-AD: Stage specific incidence of potentially remediable behavioral symptoms in aging and Alzheimer's disease: a study of 120 patients using the BEHAVE-AD. Bull Clin Neurosci 1989; 54:95-112
3. Cohen D, Eisdorfer C, Gorelick P, et al: Psychopathology associated with Alzheimer's disease and related disorders. J Gerontol 1993; 48:M225-M260
4. Teri L, Larson E, Reifler BV: Behavioral disturbances in dementia of the Alzheimer's type. J Am Geriatr Soc 1988; 36:1-6
5. Patterson MB, Bolger JP: Assessment of behavioral symptoms in Alzheimer's disease. Alz Dis Assoc Disord 1994; 8(suppl 3):4-20
6. Mega MS, Cummings JL, Fiorello T, et al: The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996; 46:130-135
7. Palmer AM, DeKosky ST: Monoamine neurons in aging and Alzheimer's disease. J Neural Transm [Gen Sect] 1993; 91:135-159
8. Raskind MA, Peskind ER: Neurologic bases of noncognitive behavioral problems in Alzheimer's disease. Alz Dis Assoc Disord 1994; 8(suppl 3):54-60
9. Cummings JL, Kaufer DI: Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 1996; 47:876-883
10. Rabins PV, Mace NL, Lucas MJ: The impact of dementia on the family. JAMA 1982; 248:333-335
11. Schulz R, O'Brien AT, Bookwala J, et al: Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. The Gerontologist 1995; 35:771-791
12. Kaufer DI, Cummings JL, Christine D, et al: Assessing the impact of behavioral disturbances in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc 1998; 46:210-215
13. Mangone CA, Sanguinetti RM, Baumann PD, et al: Influence of feelings of burden on the caregiver's perception of the patient's functional status. Dementia 1993; 4:287-293
14. Mittleman MS, Ferris SH, Shulman E, et al: A family intervention to delay nursing home placement of patients with Alzheimer's disease: a randomized controlled trial. JAMA 1996; 276:1725-1731
15. Weiner MF, Koss E, Wild KV, et al: Measures of psychiatric symptoms in Alzheimer patients: a review. Alz Dis Assoc Disord 1996; 10:20-30
16. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975; 12:189-198
17. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
18. Reisberg B, Borenstein J, Salob SP, et al: Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987; 48(suppl 5):9-15
19. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296
20. Kaufer DI, Cummings JL, Christine D: Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. J Geriatr Psychiatry Neurol 1996; 9:1-6
21. Kaufer DI, Cummings JL, Christine D: Differential neuropsychiatric symptom responses to tacrine in Alzheimer's disease: relationship to dementia severity. J Neuropsychiatry Clin Neurosci 1998; 10:55-63
22. Morris JC, Cyrus PA, Orazem J, et al: Metrifonate benefits cognitive, behavioral, and global function in patients with AD. Neurology 1998; 50:1222-1230
23. Kaufer DI: Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase-inhibitors on neuropsychiatric symptoms in Alzheimer's disease. Dement Geriatr Cogn Disord 1998; 9(suppl 2):8-14
24. Kaufer DI, Pollock BG, Catt KE, et al: An open-label study of donepezil in Alzheimer's Disease: neuropsychiatric symptom responses and caregiver distress (abstract). Neurology 1998; 50(suppl 4):A89
25. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34:939-944